Vetiqure

Vetiqure is a Swedish veterinary oncology company commercializing vetIQure, a tumour-specific electroporation system for the treatment of cancer in animals. The company is a wholly owned subsidiary of Scandinavian ChemoTech and applies its patented Tumour Specific Electroporation (TSE) platform to enhance delivery of cytotoxic drugs into tumour cells while aiming to spare healthy tissue. Its products are positioned for veterinary use across pets and horses, including tumours in sensitive or hard-to-reach locations, and can be used alone or alongside surgery and chemotherapy. Vetiqure appears to be in the commercial stage, with installations, rental agreements, and expanding clinical and commercial collaborations in Europe and North America. The business is focused on veterinary cancer care rather than human therapeutics.